Paulson & CO. Inc. increased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 121.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,105,741 shares of the biopharmaceutical company’s stock after purchasing an additional 605,741 shares during the quarter. Madrigal […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $356.73 Consensus PT from Analysts tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Madrigal Pharmaceuticals (NASDAQ:MDGL) Posts Quarterly Earnings Results, Misses Expectations By $1.32 EPS tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.